(CSL:Australian Stock Exchange Ltd)
Andrew Cuthbertson BMedSci, MBBS, Ph.D.
Chief Scientific officer and Director of R&D, CSL Ltd.
|Age||Total Calculated Compensation||This person is connected to 2 board members in 1 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Andrew Cuthbertson, BMedSci, MBBS, Ph.D., serves as Chief Scientific Officer and Research & Development Director of CSL Behring LLC. Dr. Cuthbertson manages an internal R&D budget of over $350m, and a global Research & Development organisation of 800 scientists. He is responsible for crafting the global R&D strategy for CSL. Dr. Cuthbertson joined in CSL Behring LLC 1997 as Research Director. Dr. Cuthbertson spent five years doing molecular biology research as a ...
45 Poplar RoadPhone: 61 3 9389 1911
Parkville, Victoria 3052
Fax: 61 3 9389 1434
Board Members Memberships*
Education*There is no Education data available.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Flemming Ornskov M.D., MBA, MPH||Managing Director, Chief Executive Officer and Director|
|Victor Grifols Roura||Chairman, Chief Executive Officer, President, Managing Director and Member of Appointments & Remuneration Committee|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|--||Compensation as of Fiscal Year 2013.|